SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-037705
Filing Date
2017-07-21
Accepted
2017-07-21 17:00:13
Documents
2
Period of Report
2017-07-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v471186_8k.htm 8-K 15510
2 EXHIBIT 99.1 v471186_ex99-1.htm EX-99.1 10936
  Complete submission text file 0001144204-17-037705.txt   27902
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 17977080
SIC: 2836 Biological Products, (No Diagnostic Substances)